{"DataElement":{"publicId":"4983629","version":"1","preferredName":"Gastrointestinal Stromal Tumor American Joint Committee on Cancer (AJCC) Edition 7 Gastric GIST Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for gastric GIST, also to be used for omentum.","longName":"4982921v1.0:4983593v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"4982921","version":"1","preferredName":"Gastrointestinal Stromal Tumor Gastric Stage Grouping","preferredDefinition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases._Relating to the stomach._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2875746v1.0:4982919v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2875746","version":"1","preferredName":"Gastrointestinal Stromal Tumor","preferredDefinition":"GIST. A type of tumor that usually begins in cells in the wall of the gastrointestinal tract.  It can be benign or malignant.","longName":"C3868","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69CC3F8C-54D3-DD89-E040-BB89AD4301CB","latestVersionIndicator":"Yes","beginDate":"2009-05-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-13","modifiedBy":"ONEDATA","dateModified":"2009-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4982919","version":"1","preferredName":"Gastric Stage Grouping","preferredDefinition":"Relating to the stomach.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"C13307:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E24C8C0-CD02-8E55-E050-BB89AD435158","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E24C8C0-CD13-8E55-E050-BB89AD435158","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4983593","version":"1","preferredName":"Gastrointestinal Stromal Tumor Gastric GIST American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A gastrointestinal stromal tumor that arises from the stomach.  It covers a spectrum of benign to malignant soft tissue neoplasms and includes most gastric smooth muscle tumors, leiomyoblastomas, and tumors formerly called gastrointestinal autonomic nerve tumors._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"4983593v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IIIB","valueDescription":"Stage IIIB Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983595","version":"1","preferredName":"Stage IIIB Gastric Gastrointestinal Stromal Tumor","longName":"4983595","preferredDefinition":"Stage IIIB includes: T4, N0, M0, Mitotic rate: High. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87829","definition":"Stage IIIB includes: T4, N0, M0, Mitotic rate: High. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-76A4-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-76BD-A24F-E050-BB89AD43469E","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983597","version":"1","preferredName":"Stage IB Gastric Gastrointestinal Stromal Tumor","longName":"4983597","preferredDefinition":"Stage IB includes: T3, N0, M0, Mitotic rate: Low.  T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87826","definition":"Stage IB includes: T3, N0, M0, Mitotic rate: Low.  T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-76CA-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-76E3-A24F-E050-BB89AD43469E","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983599","version":"1","preferredName":"Stage IA Gastric Gastrointestinal Stromal Tumor","longName":"4983599","preferredDefinition":"Stage IA includes: T1 or T2, N0, M0, Mitotic rate: Low.  T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87825","definition":"Stage IA includes: T1 or T2, N0, M0, Mitotic rate: Low.  T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-76F0-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-7709-A24F-E050-BB89AD43469E","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983601","version":"1","preferredName":"Stage II Gastric Gastrointestinal Stromal Tumor","longName":"4983601","preferredDefinition":"Stage II includes: (T1, N0, M0, Mitotic rate: High); (T2, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: Low). T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension.  T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87827","definition":"Stage II includes: (T1, N0, M0, Mitotic rate: High); (T2, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: Low). T1: Tumor 2 cm or less in greatest dimension.  T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension.  T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-7716-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-772F-A24F-E050-BB89AD43469E","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983603","version":"1","preferredName":"Stage IIIA Gastric Gastrointestinal Stromal Tumor","longName":"4983603","preferredDefinition":"Stage IIIA includes: T3, N0, M0, Mitotic rate: High. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87828","definition":"Stage IIIA includes: T3, N0, M0, Mitotic rate: High. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-773C-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-7755-A24F-E050-BB89AD43469E","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Gastric Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4983605","version":"1","preferredName":"Stage IV Gastric Gastrointestinal Stromal Tumor","longName":"4983605","preferredDefinition":"Stage IV includes: (Any T, N1, M0, Mitotic rate: Any rate); (Any T, Any N, M1, Mitotic rate: Any rate). N1: Regional lymph node metastasis. M0: No distant metastasis.  M1: Distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Gastric Gastrointestinal Stromal Tumor","conceptCode":"C87830","definition":"Stage IV includes: (Any T, N1, M0, Mitotic rate: Any rate); (Any T, Any N, M1, Mitotic rate: Any rate). N1: Regional lymph node metastasis. M0: No distant metastasis.  M1: Distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-7762-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-777B-A24F-E050-BB89AD43469E","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E28A2C8-7785-A24F-E050-BB89AD43469E","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4983592","version":"1","preferredName":"Gastric Gastrointestinal Stromal Tumor American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A gastrointestinal stromal tumor that arises from the stomach.  It covers a spectrum of benign to malignant soft tissue neoplasms and includes most gastric smooth muscle tumors, leiomyoblastomas, and tumors formerly called gastrointestinal autonomic nerve tumors.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C5806:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Gastrointestinal Stromal Tumor","conceptCode":"C5806","definition":"A gastrointestinal stromal tumor that arises from the stomach.  It covers a spectrum of benign to malignant soft tissue neoplasms and includes most gastric smooth muscle tumors, leiomyoblastomas, and tumors formerly called gastrointestinal autonomic nerve tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-7678-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E28A2C8-7689-A24F-E050-BB89AD43469E","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"COOPERM","dateModified":"2015-08-26","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"4982441","version":"1","longName":"Gastrointestinal Stromal Tumor","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777520","version":"1","longName":"Gastrointestinal Stromal","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease Stage - Gastric GIST","type":"Preferred Question Text","description":"Disease Stage - Gastric GIST","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"1E28FD4F-5A41-A857-E050-BB89AD435E88","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created per COG request for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}